Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis.
Haroche
Julien
J
Amoura
Zahir
Z
Charlotte
Frédéric
F
Salvatierra
Juan
J
Wechsler
Bertrand
B
Graux
Carlos
C
Brousse
Nicole
N
Piette
Jean-Charles
JC
D000328:Adult; D001549:Benzamides; D031249:Erdheim-Chester Disease / Q000188:drug therapy* / Q000378:metabolism*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism*
D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D020797:Receptor, Platelet-Derived Growth Factor beta